Additionally, using in silico analysis, Dr. Adrees and colleagues [122] identified boeravinone B as a compound that targets NEK7 and PPP1CA proteins, which are overexpressed in pancreatic ductal adenocarcinoma, suggesting that targeting NEK7 may be a promising approach for pancreatic cancer. This evidence concerns the gene NEK7 and familial pancreatic carcinoma.